Schwab Emerging Markets Equity (SCHE)

Key Updates

SCHE rebounded 2.23% to $33.18 since the March 20 report, recovering from the YTD low of $32.45 and reclaiming the critical $33.00 psychological support level. The recovery reflects stabilizing sentiment as oil prices retreated from four-year highs following diplomatic signals from US and Israeli officials regarding Iran conflict de-escalation. Despite the bounce, SCHE remains under pressure with a -6.14% decline over the past month, though YTD performance improved to +1.31%. The technical recovery occurs against a backdrop of continued institutional interest, with investors adding $12.6 billion to emerging-market stocks and bonds in the week through mid-March, suggesting buyers are capitalizing on the recent selloff.

Current Trend

SCHE exhibits a volatile recovery pattern within a broader corrective phase. The ETF's YTD performance of +1.31% represents a significant deterioration from the +15% gains achieved by the MSCI Emerging Markets Index in late February 2026. The recent 2.23% single-session gain demonstrates short-term resilience, though the fund remains 6.14% below its one-month high. Key technical levels include resistance at $33.50 (the prior support level breached on March 12) and support at $33.00. The 6-month performance of +0.45% underscores the dramatic reversal from the strong momentum that characterized early 2026, when emerging markets significantly outperformed developed markets. Current price action suggests SCHE is attempting to establish a base above $33.00, though conviction remains uncertain given the geopolitical overhang.

Investment Thesis

The investment thesis for SCHE centers on emerging markets' structural advantages including attractive valuations, superior earnings growth potential, and diversification benefits amid developed market policy uncertainty. Emerging-market equities trade at a 28% discount to developed markets while offering higher earnings growth expectations, with the MSCI EM Index projected to achieve $118 earnings per share by December 2026 (up 33% year-over-year). The thesis is reinforced by unprecedented AI-driven capital expenditure flowing into Asian semiconductor manufacturers, creating the strongest earnings growth cycle since 2002-2004. However, the thesis faces material headwinds from geopolitical instability, particularly the Iran conflict's impact on energy-dependent economies in Taiwan and South Korea, where approximately 60% of energy consumption derives from oil and gas. The concentration risk in three semiconductor firms (Samsung Electronics, SK Hynix, TSMC) supporting the entire 6.5% earnings upgrade presents additional vulnerability.

Thesis Status

The investment thesis remains intact but faces significant near-term execution risk. The fundamental drivers—valuation discounts, earnings growth, and institutional allocation shifts—continue to support the long-term case, as evidenced by major asset managers maintaining bullish outlooks despite recent volatility. Pimco, Barings, and T. Rowe Price maintain their long-term bullish outlook on emerging markets, citing attractive valuations and solid economic fundamentals. However, the thesis has been temporarily disrupted by geopolitical shocks, with the MSCI emerging markets index posting its biggest weekly drop in six years in early March. The critical test centers on oil price sustainability—investors identify sustained oil prices above $100 per barrel as the primary risk that could trigger global inflation and halt rate-cutting cycles. Current oil price stabilization below this threshold suggests the thesis can withstand the shock, though the recovery trajectory remains dependent on geopolitical clarity.

Key Drivers

The primary catalyst for SCHE's recent recovery is declining oil prices from near-four-year highs following diplomatic signals from President Trump and Prime Minister Netanyahu regarding Iran conflict de-escalation. This has alleviated immediate concerns about energy cost inflation for key EM economies. The competitive landscape is intensifying with new product launches, as T. Rowe Price launched TEMR on March 12, 2026 with a 0.40% expense ratio and MFS launched BREE on March 5, both offering active management approaches. Institutional sentiment remains constructive, with HSBC survey data showing investor sentiment toward emerging markets at the highest level since January 2021. However, structural headwinds persist as the MSCI Emerging Markets index has failed to beat the S&P 500 in consecutive years since 2010, with the S&P up approximately 7% YTD versus EM down 0.71% as of mid-March.

Technical Analysis

SCHE's technical structure shows signs of stabilization after breaking critical support. The ETF tested the $32.45 level on March 20 before staging a 2.23% recovery to $33.18, reclaiming the psychologically important $33.00 level. Immediate resistance sits at $33.50, representing the support level breached during the March selloff. A sustained move above this level would signal a potential trend reversal and target the $34.00-$34.50 zone. The 5-day performance of +0.64% suggests short-term momentum is building, though the -6.14% monthly decline indicates the broader downtrend remains in force. Volume patterns suggest institutional accumulation, with over $600 million flowing into emerging-market ETFs during the recent volatility. The 6-month performance of just +0.45% highlights the dramatic round-trip from February's record highs. Key support at $33.00 must hold to validate the recovery; a break below this level would expose the $32.45 recent low and potentially $32.00.

Bull Case

• AI capital expenditure driving strongest EM earnings growth since 2002-04, with Morgan Stanley projecting $118 EPS by December 2026 (up 33% YoY) and raising year-end target to 1,700 from 1,400, representing the most powerful fundamental catalyst in two decades concentrated in high-growth semiconductor sector.
• Emerging market equities trading at 28% discount to developed markets with higher earnings growth expectations and improved central bank credibility, creating compelling risk-reward amid geopolitical uncertainty while offering structural valuation support.
• World's largest asset managers overseeing $20+ trillion increasing allocations to EM equities, local currency bonds, and credit, driven by expectations of strong global growth and weaker dollar, providing sustained institutional demand.
• $46 billion in YTD inflows to emerging-market ETFs versus just $1 billion in same period 2025, with investors viewing geopolitical turmoil as buying opportunity and demonstrating resilience during the March selloff with continued capital allocation.
• Oil prices retreating from four-year highs following diplomatic signals on Iran conflict de-escalation, removing immediate threat of sustained $100+ oil that could trigger global inflation and derail rate-cutting cycles critical to EM recovery.

Bear Case

• MSCI EM index has failed to beat S&P 500 in consecutive years since 2010, with S&P up ~7% YTD versus EM down 0.71% as of mid-March, and Iran conflict disrupting fossil fuel traffic critical to Taiwan and South Korea where 60% of energy consumption comes from oil and gas, threatening the structural competitiveness of key index constituents.
• MSCI EM equities fell more than 6% in one week, significantly outpacing 2.2% decline in MSCI World and 0.7% drop in MSCI US, with weekly inflows slowing to $5.8 billion (lowest in seven weeks), demonstrating EM's elevated beta and vulnerability to risk-off sentiment during geopolitical shocks.
• Entire 6.5% earnings upgrade concentrated in just three semiconductor firms (Samsung, SK Hynix, TSMC) while China's earnings remain muted due to weak domestic demand, creating unprecedented concentration risk and vulnerability to any semiconductor cycle downturn or single-company execution issues.
• Goldman Sachs warns that higher valuations following strong 2024 gains leave markets vulnerable to near-term correction risks, with JPMorgan cutting EM recommendations three times in one week and reducing exposure to marketweight amid geopolitical uncertainty.
• Intensifying competition with T. Rowe Price launching TEMR (0.40% expense ratio) and MFS launching BREE, both offering active management that could pressure passive products like SCHE and fragment market share among expanding product universe.